|
| [March 01, 2013] |
 |
Research and Markets: Sensory Organs Partnering Yearbook 2013 Provides an Orientation of 2012's Dealmaking and Business Activities
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/r9cgsg/sensory_organs)
has announced the addition of the "Sensory
Organs Partnering Yearbook 2013" report to their offering.
The Sensory Organ Partnering Yearbook 2013 report series provides
comprehensive understanding and unprecedented access to the partnering
deals and agreements entered into by the worlds leading healthcare
companies during 2012.
Using these reports, dealmakers will effectively and efficiently gain
insight into the partnering activities of the past year. The report
series allows you to view all the partnering and alliances deals
announced worldwide.
The report series also includes numerous tables and figures that
illustrate the trends and activities in bigpharma partnering and
dealmaking during 2012.
In conclusion, this report provides everything a prospective dealmaker
needs to know about partnering in the resarch, development and
commercialization of technologies and products during 2012.
Key benefits
Sensory Organ Partnering Yearbook 2013 series provides the reader with
the following key benefits:
- In-depth understanding of recent dealmaking trends during 2012
- Comprehensive access to all deals entered into by the world's
biopharma companies during 2012
- Detailed access to actual partnership deals and contracts entered into
by the leading fifty bigpharma companies
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal
terms for partner companies
Companies Mentioned:
Abbott
Actavis
Actelion
Allergan
Amgen
Aspen Pharmacare
Astellas
AstraZeneca
Baxter International
Bayer
Biogen Idec
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
CSL
Daiichi Sankyo
Dainippon Sumitomo
Eisai
Eli Lilly
Endo Pharmaceuticals
Forest Laboratories
Galderma
Gilead Sciences
GlaxoSmithKline
Grifols
Hospira
Johnson & Johnson
Kyowa Hakko Kirin
Lundbeck
Menarini
Merck & Co
Merck KGaA
Mitsubishi (News - Alert) Tanabe
Novartis
Novo Nordisk
Otsuka
Pfizer
Purdue
Roche
Sanofi
Servier
Shionogi
Shire
Takeda
Teva
Valeant
Warner Chilcott
Watson
For more information visit http://www.researchandmarkets.com/research/r9cgsg/sensory_organs

[ Back To Technology News's Homepage ]
|